Palisade Cash And Short Term Investments vs Other Current Liab Analysis
PALI Stock | USD 6.36 0.10 1.55% |
Palisade Bio financial indicator trend analysis is much more than just breaking down Palisade Bio prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Palisade Bio is a good investment. Please check the relationship between Palisade Bio Cash And Short Term Investments and its Other Current Liab accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Palisade Bio. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. For more detail on how to invest in Palisade Stock please use our How to Invest in Palisade Bio guide.
Cash And Short Term Investments vs Other Current Liab
Cash And Short Term Investments vs Other Current Liab Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Palisade Bio Cash And Short Term Investments account and Other Current Liab. At this time, the significance of the direction appears to have weak contrarian relationship.
The correlation between Palisade Bio's Cash And Short Term Investments and Other Current Liab is -0.17. Overlapping area represents the amount of variation of Cash And Short Term Investments that can explain the historical movement of Other Current Liab in the same time period over historical financial statements of Palisade Bio, assuming nothing else is changed. The correlation between historical values of Palisade Bio's Cash And Short Term Investments and Other Current Liab is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cash And Short Term Investments of Palisade Bio are associated (or correlated) with its Other Current Liab. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Other Current Liab has no effect on the direction of Cash And Short Term Investments i.e., Palisade Bio's Cash And Short Term Investments and Other Current Liab go up and down completely randomly.
Correlation Coefficient | -0.17 |
Relationship Direction | Negative |
Relationship Strength | Insignificant |
Cash And Short Term Investments
Short Term Investments is an account in the current assets section of Palisade Bio balance sheet. This account contains Palisade Bio investments that will expire within one year. These investments include stocks and bonds that can be liquidated by Palisade Bio fairly quickly. The sum of a company's cash on hand, including bank deposits and short-term, highly liquid investments that are easily convertible to known amounts of cash.Other Current Liab
Most indicators from Palisade Bio's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Palisade Bio current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Palisade Bio. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. For more detail on how to invest in Palisade Stock please use our How to Invest in Palisade Bio guide.As of now, Palisade Bio's Enterprise Value Multiple is increasing as compared to previous years.
2021 | 2023 | 2024 (projected) | Reconciled Depreciation | 2K | 4K | 3.3K | Cost Of Revenue | 168K | 4K | 3.8K |
Palisade Bio fundamental ratios Correlations
Click cells to compare fundamentals
Palisade Bio Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Palisade Bio fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 6.6M | 3.0M | 12.5M | 15.8M | 14.1M | 12.3M | |
Other Current Liab | 368.0K | 3.3M | 779K | 991K | 1.6M | 1.0M | |
Total Current Liabilities | 1.2M | 8.1M | 2.5M | 3.0M | 2.6M | 3.4M | |
Total Stockholder Equity | 5.1M | (16.6M) | 7.4M | 12.5M | 11.3M | 6.2M | |
Property Plant And Equipment Net | 242.7K | 280K | 112K | 310K | 208K | 233.1K | |
Net Debt | (4.9M) | 708K | (10.3M) | (12.0M) | (12.1M) | (11.5M) | |
Retained Earnings | (222.0M) | (68.0M) | (94.6M) | (109.2M) | (121.5M) | (127.6M) | |
Accounts Payable | 824.4K | 3.6M | 1.5M | 1.8M | 698K | 663.1K | |
Cash | 5.1M | 713K | 10.5M | 12.4M | 12.4M | 8.5M | |
Non Current Assets Total | 937.0K | 2.1M | 138K | 1.0M | 836K | 1.1M | |
Non Currrent Assets Other | 25.3K | 1.8M | 26K | 694K | 602K | 326.6K | |
Cash And Short Term Investments | 5.1M | 713K | 10.5M | 12.4M | 12.4M | 10.4M | |
Common Stock Total Equity | 151.6K | 182.1K | 38.7K | 173.0K | 155.7K | 147.9K | |
Common Stock Shares Outstanding | 7.3K | 55.5K | 187.0K | 880.3K | 456.0K | 478.8K | |
Liabilities And Stockholders Equity | 6.6M | 3.0M | 12.5M | 15.8M | 14.1M | 12.3M | |
Non Current Liabilities Total | 233.1K | 11.5M | 2.7M | 272K | 153K | 145.4K | |
Other Current Assets | 510.9K | 2.4M | 1.9M | 2.4M | 636K | 822.0K | |
Other Stockholder Equity | 227.1M | 51.4M | 101.9M | 121.6M | 132.7M | 139.7M | |
Total Liab | 1.5M | 19.6M | 5.1M | 3.3M | 2.7M | 2.6M | |
Property Plant And Equipment Gross | 268.1K | 10.8K | 112K | 310K | 208K | 218.2K | |
Total Current Assets | 5.6M | 896K | 12.4M | 14.7M | 13.2M | 11.2M | |
Intangible Assets | 883.5K | 763.5K | 668.9K | 147.1K | 169.2K | 160.7K | |
Common Stock | 38.7K | 28K | 143K | 30K | 93K | 88.4K | |
Net Receivables | 21.1K | 59K | 150K | 1.4M | 148K | 264.5K | |
Other Assets | 13.9K | 24.0K | 26K | 157.6K | 29.9K | 48.2K | |
Capital Surpluse | 217.1M | 219.5M | 227.1M | 247.8M | 285.0M | 245.4M | |
Property Plant Equipment | 5K | 420K | 280K | 112K | 100.8K | 167.9K |
Currently Active Assets on Macroaxis
When determining whether Palisade Bio offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Palisade Bio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Palisade Bio Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Palisade Bio Stock:Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Palisade Bio. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. For more detail on how to invest in Palisade Stock please use our How to Invest in Palisade Bio guide.You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Complementary Tools for Palisade Stock analysis
When running Palisade Bio's price analysis, check to measure Palisade Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Palisade Bio is operating at the current time. Most of Palisade Bio's value examination focuses on studying past and present price action to predict the probability of Palisade Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Palisade Bio's price. Additionally, you may evaluate how the addition of Palisade Bio to your portfolios can decrease your overall portfolio volatility.
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |
Is Palisade Bio's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Palisade Bio. If investors know Palisade will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Palisade Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (27.00) | Revenue Per Share 0.548 | Return On Assets (0.54) | Return On Equity (1.03) |
The market value of Palisade Bio is measured differently than its book value, which is the value of Palisade that is recorded on the company's balance sheet. Investors also form their own opinion of Palisade Bio's value that differs from its market value or its book value, called intrinsic value, which is Palisade Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Palisade Bio's market value can be influenced by many factors that don't directly affect Palisade Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Palisade Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Palisade Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Palisade Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.